Xconomy National

by in

Entry	Author	Date	Location
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO	Luke Timmerman	12/06/11	Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster	Luke Timmerman	10/26/10	Seattle
Swine Flu Spurs Investor Interest in San Diego Biomedical Firms	Denise Gellene	09/21/09	San Diego
Finding HIV’s Weak Spot, Scientists at Seattle’s Theraclone and San Diego’s Scripps See Opening for New Vaccine	Luke Timmerman	09/03/09	National
Intellikine Raises $28.5M, Cadence Awaits FDA Action, Somaxon Seeks FDA Approval Again for Insomnia Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	07/09/09	San Diego
Vical Encouraged by CMV Study	Denise Gellene	07/08/09	San Diego
Anadys Cuts Jobs, Obesity Drug Developers Show Intriguing Results, Trius Antibiotic Passes Key Test, & More San Diego Life Sciences News	Bruce V. Bigelow	06/11/09	San Diego
After Years of Red Ink, Vical Says DNA-Based Vaccines ‘Ready for Prime Time.’	Denise Gellene	06/09/09	San Diego
Page 1 of 1